Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 06, 2020

SELL
$24.28 - $49.8 $169,960 - $348,600
-7,000 Closed
0 $0
Q4 2019

Feb 11, 2020

BUY
$24.84 - $45.46 $173,880 - $318,220
7,000 New
7,000 $318,000
Q1 2019

Apr 15, 2019

SELL
$14.02 - $16.74 $149,046 - $177,962
-10,631 Closed
0 $0
Q4 2018

Feb 12, 2019

BUY
$10.95 - $15.44 $116,409 - $164,142
10,631 New
10,631 $156,000

Others Institutions Holding ZYME

About Zymeworks Inc.


  • Ticker ZYME
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,694,400
  • Market Cap $759M
  • Description
  • Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...
More about ZYME
Track This Portfolio

Track Quantitative Systematic Strategies LLC Portfolio

Follow Quantitative Systematic Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.